
Find Clinical Trials Near You with ALK Clinical Trial Finder
The ALK Positive Clinical Trial Finder is a patient-centered tool designed to help individuals with ALK-positive cancer quickly identify relevant clinical trials based on their diagnosis, treatment history, and location.
Highlighted- Recruiting Trials
Gilteritinib for ALK-positive Lung Cancer
Trial ID: NCT06225427
Phase: Phase 1
Status: Recruiting
Researchers are studying whether the targeted therapy gilteritinib may help treat ALK-positive lung cancer that has progressed after prior ALK inhibitors.
Gilteritinib in Advanced ALK-positive NSCLC
Trial ID: NCT07140016
Phase: Phase 1
Status: Recruiting
This study is evaluating the safety and recommended dose of gilteritinib in patients with advanced ALK-positive lung cancer who have previously received targeted therapies.
Hear directly from those who’ve participated in clinical trials:
Clinical trials play an important role in advancing new treatments for people living with ALK-positive lung cancer. In this video, hear directly from a patient who chose to participate in a clinical trial and shares what the experience was like—from deciding to enroll, to working with their care team, and why research continues to matter for the ALK+ community.
Watch the video below to learn more about their journey and perspective on participating in clinical research.
Find Clinical Trials Near You with ALK Clinical Trial Finder
The ALK Positive Clinical Trial Finder is a patient-centered tool designed to help individuals with ALK-positive cancer quickly identify relevant clinical trials based on their diagnosis, treatment history, and location.
